e-space
Manchester Metropolitan University's Research Repository

    Influence of menstrual cycle and oral contraceptive phases on bone (re)modelling markers in response to interval running

    Guisado-Cuadrado, Isabel ORCID logoORCID: https://orcid.org/0000-0002-1767-5341, Romero-Parra, Nuria ORCID logoORCID: https://orcid.org/0000-0001-9754-5565, Elliott-Sale, Kirsty J ORCID logoORCID: https://orcid.org/0000-0003-1122-5099, Sale, Craig ORCID logoORCID: https://orcid.org/0000-0002-5816-4169, Díaz, Ángel E ORCID logoORCID: https://orcid.org/0000-0002-6215-0093 and Peinado, Ana B ORCID logoORCID: https://orcid.org/0000-0002-4871-8682 (2024) Influence of menstrual cycle and oral contraceptive phases on bone (re)modelling markers in response to interval running. Calcified Tissue International, 115. pp. 382-392. ISSN 0171-967X

    [img]
    Preview
    Published Version
    Available under License Creative Commons Attribution.

    Download (895kB) | Preview

    Abstract

    To explore how sex hormone fluctuations may affect bone metabolism, this study aimed to examine P1NP and β-CTX-1 concentrations across the menstrual and oral contraceptive (OC) cycle phases in response to running. 17β-oestradiol, progesterone, P1NP and β-CTX-1 were analysed pre- and post-exercise in eight eumenorrheic females in the early-follicular, late-follicular, and mid-luteal phases, while 8 OC users were evaluated during the withdrawal and active pill-taking phases. The running protocol consisted of 8 × 3min treadmill runs at 85% of maximal aerobic speed. 17β-oestradiol concentrations (pg·ml−1) were lower in early-follicular (47.22 ± 39.75) compared to late-follicular (304.95 ± 235.85;p = < 0.001) and mid-luteal phase (165.56 ± 80.6;p = 0.003) and higher in withdrawal (46.51 ± 44.09) compared to active pill-taking phase (10.88 ± 11.24;p < 0.001). Progesterone (ng·ml−1) was higher in mid-luteal (13.214 ± 4.926) compared to early-follicular (0.521 ± 0.365; p < 0.001) and late-follicular phase (1.677 ± 2.586;p < 0.001). In eumenorrheic females, P1NP concentrations (ng·ml−1) were higher in late-follicular (69.97 ± 17.84) compared to early-follicular (60.96 ± 16.64;p = 0.006;) and mid-luteal phase (59.122 ± 11.77;p = 0.002). β-CTX-1 concentrations (ng·ml−1) were lower in mid-luteal (0.376 ± 0.098) compared to late-follicular (0.496 ± 0.166; p = 0.001) and early-follicular phase (0.452 ± 0.148; p = 0.039). OC users showed higher post-exercise P1NP concentrations in withdrawal phase (61.75 ± 8.32) compared to post-exercise in active pill-taking phase (45.45 ± 6;p < 0.001). Comparing hormonal profiles, post-exercise P1NP concentrations were higher in early-follicular (66.91 ± 16.26;p < 0.001), late-follicular (80.66 ± 16.35;p < 0.001) and mid-luteal phases (64.57 ± 9.68;p = 0.002) to active pill-taking phase. These findings underscore the importance of studying exercising females with different ovarian hormone profiles, as changes in sex hormone concentrations affect bone metabolism in response to running, showing a higher post-exercise P1NP concentrations in all menstrual cycle phases compared with active pill-taking phase of the OC cycle.

    Impact and Reach

    Statistics

    Activity Overview
    6 month trend
    75Downloads
    6 month trend
    38Hits

    Additional statistics for this dataset are available via IRStats2.

    Altmetric

    Repository staff only

    Edit record Edit record